Scott Giacobello has been appointed chief financial officer at GW Pharmaceuticals, reporting to chief executive officer Justin Gover. Mr. Giacobello will be based at the company’s U.S. headquarters in Carlsbad, CA. He succeeds Adam George, who will serve as managing director – UK, a newly-created executive role with leadership responsibilities for UK operations. “These important leadership appointments reflect GW’s continuing evolution into a transatlantic commercial-stage biopharmaceutical ...